2 completed, 2 terminated, 2 unknown, 1 recruiting. 8 Phase 2, 3 Phase 3, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Completed 2, Terminated 2, Unknown 2, Recruiting 1, Withdrawn 1 |
| Phase 3 | 3 | Completed 1, Terminated 1, Unknown 1 |
| Phase 1 | 2 | Terminated 1, Withdrawn 1 |
Follow Peripheral Arterial Occlusive Disease: new trials by email Literature Review of Peripheral Arterial Occlusive Disease trials Research Report on Peripheral Arterial Occlusive Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety of Antithrombotic Heparin Proteoglycan Mimetic APAC in Peripheral Arterial Occlusive Disease and Chronic Limb-threatening Ischemia APAC - dose level 0.50 mg/kg,, Unfractionated heparin (UFH), APAC dose level 1: 0.25 mg/kg, - Peripheral Arterial Occlusive Disease, Chronic Limb-Threatening Ischemia | Phase 2 | Recruiting | Aplagon Oy | 42 | 2026-01-29 | 2026-04-09 |
| Allogeneic ABCB5-positive Stem Cells for Treatment of PAOD allo-APZ2-PAOD, Placebo - Peripheral Arterial Occlusive Disease | Phase 1 / Phase 2 | Terminated | RHEACELL GmbH & Co. KG | 24 | 2018-03-05 | 2020-06-29 |
| Autologous BMMNC Combined With HA Therapy for PAOD RV-P1501 - Peripheral Arterial Occlusive Disease, Critical Limb Ischemia | Phase 1 / Phase 2 | Withdrawn | Academia Sinica, Taiwan | 2017-01-17 | 2022-03-15 | |
| The Arterial Measurement of the Blood Flow Volume After Iloprost Stimulation Ilomedin - Diabetes, Arteriosclerosis | Phase 2 | Unknown | Prim PD Dr Afshin Assadian | 100 | 2012-10-01 | 2018-10-17 |
| EXCimEr Laser for Long lENgTh Lesions in Below-The-Knee Arteries Study Spectranetics Turbo elite™ excimer laser catheter - Peripheral Arterial Occlusive Disease | Phase 2 / Phase 3 | Terminated | Flanders Medical Research Program | 14 | 2008-07-01 | 2015-03-09 |
| FeMoropopliteal AngioSculpt™ SCoring BallOon CaTheter Study 4.0-5.0mm AngioSculpt Scoring Balloon Catheter - Peripheral Arterial Occlusive Disease | Phase 2 / Phase 3 | Completed | Flanders Medical Research Program | 50 | 2008-03-01 | 2010-07-05 |
| Autologous Bone Marrow Stem Cell Transplantation for Critical, Limb-threatening Ischemia Autologous bone marrow cell concentrate transplantation, saline injection - Peripheral Vascular Disease, Diabetic Foot | Phase 2 / Phase 3 | Unknown | Franziskus-Krankenhaus | 90 | 2007-04-01 | 2011-04-06 |
| Dose-finding, Safety and Efficacy Study of NV1FGF in Patients With Intermittent Claudication XRP0038 (NV1FGF), placebo - Peripheral Arterial Occlusive Disease | Phase 2 | Completed | Sanofi | 36 | 2004-06-01 | 2010-07-07 |
Peripheral Arterial Occlusive Disease 1 (8) · Chronic Limb-Threatening Ischemia (2) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Diabetes Mellitus (1) · Diabetic Foot (1) · Gangrene (1) · Ischemia (1) · Leg Ulcer (1) · Peripheral Vascular Diseases (1)
Cardiovascular Diseases (4) · Vascular Diseases (4) · Arterial Occlusive Diseases (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Arteriosclerosis (2) · Atherosclerosis (2) · Chronic Disease (2) · Disease Attributes (2) · Endocrine System Diseases (2) · Ischemia (2) · Peripheral Arterial Disease (2) · Peripheral Vascular Diseases (2) · Diabetes Complications (1) · Diabetes Mellitus (1)
Sodium Chloride (2) · Heparin (1) · Injections (1) · Solvents (1)
Flanders Medical Research Program (2) · Academia Sinica, Taiwan (1) · Aplagon Oy (1) · Franziskus-Krankenhaus (1) · Prim PD Dr Afshin Assadian (1) · RHEACELL GmbH & Co. KG (1) · Sanofi (1)
Germany (4) · Belgium (3) · Austria (2) · Czechia (1) · Finland (1) · Poland (1) · Switzerland (1) · Taiwan (1) · United Kingdom (1) · United States (1)
Patrick Peeters, MD (2) · Afshin Assadian, Prim PD Dr (1) · Berthold Amann, MD (1) · Jarna Hannukainen (1) · Marc Bosiers, MD (1)
2025 (1)